L-arginine abolishes the anxiolytic-like effect of withaferin a in the elevated plus-maze test in rats

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The involvement of nitrergic mechanisms in the behavioural effects of withaferin A in rats was studied in the elevated plus-maze, open-field and rotarod tests. Administration of the nitric oxide (NO) precursor L-arginine (100 mg/kg, i.p.), assumed to increase the synthesis of NO, abolished the anxiolytic-like effect of withaferin A (40 mg/kg, i.p.) in the elevated plus-maze, whereas the inactive enantiomer D-arginine (100 mg/kg) did not. Neither withaferin A alone nor in combination with L- or Darginine affected the exploratory activity of animals in the open field. Pretreatment with L-arginine (100 and 200 mg/kg) did not modify the motor impairment of rats after withaferin A (40 mg/kg) in the rotarod test. Withaferin A (40 mg/kg i.p.) did inhibit the brain NO synthase activity measured ex vivo by NOx assay. We conclude that a suppression of NO synthase activity may be important in the anxiolytic-like effect of withaferin A. © 2011 Academic Journals.

Cite

CITATION STYLE

APA

Khan, Z. A., & Ghosh, A. R. (2011). L-arginine abolishes the anxiolytic-like effect of withaferin a in the elevated plus-maze test in rats. African Journal of Pharmacy and Pharmacology, 5(2), 234–237. https://doi.org/10.5897/AJMR10.401

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free